We are live on !
Find out more
Bleichroeder Portfolio holdings
AUM
$1.02B
Turnover
33.63%
1-Year Est. Return
33%
This Fund
S&P 500
This Quarter Est. Return
-3.15%
1 Year Est. Return
+33%
3 Year Est. Return
+222.49%
5 Year Est. Return
+219.92%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$457M
(+82%)
Cap. Flow
+$530M
Cap. Flow % of AUM
Cap. Flow %
52.15%
Top 10 Holdings %
Top 10 Hldgs %
44.01%
Holding
113
New
35
Increased
8
Reduced
7
Closed
3
Avg Time Held
2
years
Top 10 Avg Time Held
2.1
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pasqal Holding SA Ordinary Share
PSQL
|
+$31.7M |
| 2 |
Medline Inc
MDLN
|
+$18.4M |
| 3 |
Broadcom
AVGO
|
+$17.9M |
| 4 |
Agilent Technologies
A
|
+$17.9M |
| 5 |
TSMC
TSM
|
+$17.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Opus Genetics
IRD
|
+$2.08M |
| 2 |
Linde
LIN
|
+$1.77M |
| 3 |
Owlet
OWLT
|
+$987K |
| 4 |
5E Advanced Materials
FEAM
|
+$638K |
| 5 |
PayPal
PYPL
|
+$220K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.67% |
| 2 | Technology | 20.28% |
| 3 | Industrials | 15.62% |
| 4 | Financials | 13.79% |
| 5 | Healthcare | 12.72% |
Similar funds
KL
Bleichroeder's Q3 2026 Portfolio in Review
As of Q3 2026, Bleichroeder held 113 positions worth $1.02B, up 82% from $559M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Bleichroeder deployed $530M of net new capital in Q3 2026, opening 35 new positions and adding to 8 existing holdings. Its largest new stake was Pasqal Holding SA Ordinary Share: 3,496,313 shares worth $22.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Opus Genetics, an estimated $2.08M trimmed.
- Bleichroeder's largest Q3 2026 buy was Pasqal Holding SA Ordinary Share: 3,496,313 shares worth $22.2M.
- Bleichroeder added most to S&P Global in Q3 2026, an estimated $16M increase.
- Bleichroeder's biggest Q3 2026 reduction was Opus Genetics, cutting an estimated $2.08M.
- Bleichroeder fully exited Owlet in Q3 2026, selling an estimated $987K.
- Bleichroeder's ten largest holdings make up 44% of its $1.02B portfolio in Q3 2026.
- Bleichroeder opened 35 new positions and closed 3 in Q3 2026.
- Bleichroeder's portfolio value rose 82% quarter-over-quarter to $1.02B.
Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.